Biggest Insulin Maker May Build Diabetes Drug Plant in U.S.Makiko Kitamura and Albertina Torsoli
About 90 minutes from Copenhagen, at a site the size of 140 soccer fields, the world’s largest maker of insulin runs its only factory making active ingredients for diabetes therapies. Novo Nordisk A/S may soon change that with a new U.S. facility.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.